Annual report pursuant to Section 13 and 15(d)

STOCK BASED COMPENSATION.

v3.8.0.1
STOCK BASED COMPENSATION.
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION.
13. STOCK-BASED COMPENSATION.

 

The Company has two equity incentive compensation plans: a 2006 Stock Incentive Plan and a 2016 Stock Incentive Plan.

 

2006 Stock Incentive Plan – The 2006 Stock Incentive Plan authorized the issuance of incentive stock options (“ISOs”) and non-qualified stock options (“NQOs”), restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company for up to an aggregate of 1,715,000 shares of common stock. In June 2016, this plan was terminated, except to the extent of issued and outstanding unvested stock awards and options.

 

2016 Stock Incentive Plan – On June 16, 2016, the Company’s shareholders approved the 2016 Stock Incentive Plan, which authorizes the issuance of ISOs, NQOs, restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company for up to an aggregate of 1,150,000 shares of common stock.

 

Stock Options – Summaries of the status of Company’s stock option plans as of December 31, 2017 and 2016 and of changes in options outstanding under the Company’s plans during those years are as follows (number of shares in thousands):

 

    Years Ended December 31,  
    2017     2016  
    Number
of Shares
    Weighted Average Exercise Price     Number
of Shares
    Weighted Average
Exercise Price
 
Outstanding at beginning of year     240     $ 4.18       240     $ 4.18  
Exercised     (10 )     3.74              
Outstanding at end of year     230     $ 4.18       240     $ 4.18  
Options exercisable at end of year     230     $ 4.18       240     $ 4.18  

 

Stock options outstanding as of December 31, 2017 were as follows (number of shares in thousands): 

 

          Options Outstanding       Options Exercisable  
  Range of
Exercise Prices
     

Number 

Outstanding 

      Weighted Average Remaining Contractual Life (yrs.)      

Weighted Average 

 Exercise

 Price

      Number Exercisable      

Weighted

 Average

 Exercise 

Price

 
                                             
$ 3.74       219       5.47     $ 3.74       219     $ 3.74  
$ 12.90       11       3.59     $ 12.90       11     $ 12.90  

 

The options outstanding at December 31, 2017 and 2016 had intrinsic values of $84,000 and $1,319,000, respectively. The intrinsic value of options exercised in 2017 was approximately $30,000.

  

Restricted Stock – The Company granted to certain employees and directors shares of restricted stock under its 2006 and 2016 Stock Incentive Plans. A summary of unvested restricted stock activity is as follows (shares in thousands):

 

    Number of
Shares
    Weighted
Average
Grant Date
 Fair Value
Per Share
 
Unvested at December 31, 2014     390     $ 8.71  
Issued     307     $ 10.16  
Vested     (220 )   $ 7.94  
Canceled     (14 )   $ 10.08  
Unvested at December 31, 2015     463     $ 10.00  
Issued     742     $ 5.24  
Vested     (250 )   $ 9.01  
Canceled     (25 )   $ 6.24  
Unvested at December 31, 2016     930     $ 6.57  
Issued     664     $ 6.65  
Vested     (480 )   $ 7.30  
Canceled     (37 )   $ 6.08  
Unvested at December 31, 2017     1,077     $ 6.31  

 

The fair value of the common stock at vesting aggregated $3,210,000, $1,142,000 and $2,603,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in selling, general and administrative expenses, were as follows (in thousands):

 

    Years Ended December 31,  
    2017     2016     2015  
Employees   $ 3,303     $ 2,173     $ 1,694  
Non-employees     525       443       325  
Total stock-based compensation expense   $ 3,828     $ 2,616     $ 2,019  

 

Employee grants typically have a three year vesting schedule, while the non-employee grants have a one year vesting schedule. At December 31, 2017, the total compensation expense related to unvested awards which had not been recognized was $4,122,000 and the associated weighted-average period over which the compensation expense attributable to those unvested awards will be recognized was approximately 1.54 years.